MIDMICHIGAN MEDICAL CENTER - GLADWIN — History
CCN 231325 | 3-year financial timeline | COVID resilience: 82/100
🛡️ Public data only — no PHI permitted on this instance.
$46M
Latest Revenue (FY2022)
+11.0%
Revenue CAGR (3yr)
8.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $37M | $44M | $46M | +3.3% | +11.0% |
| Operating Expenses | $38M | $40M | $42M | +5.5% | +4.6% |
| Operating Margin | -3.2% | 10.3% | 8.4% | -18.3% | +0.0% |
| Net Income | $-1M | $5M | $4M | -15.6% | +0.0% |
| Licensed Beds | 25 | 25 | 25 | +0.0% | +0.0% |
| Total Patient Days | 1,213 | 1,410 | 1,126 | -20.1% | -3.7% |
| Medicare Day % | 46% | 35% | 43% | +22.7% | -3.2% |
| Medicaid Day % | 12% | 2% | 0% | -85.6% | -85.0% |
COVID Impact & Recovery
Resilience Score: 82/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +23.2% ($37M → $46M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+11.0%
This Hospital
+7.6%
State Avg
Latest Margin
8.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $50M | 14.3% |
| FY2024 (proj) | $54M | 20.1% |
| FY2025 (proj) | $59M | 25.9% |